TRIATEC
As listed in the register: TRIATEC 2,5 mg, comprimé sécable
2,5 mg · comprimé sécable
- Prescription only
- Active substance
- Ramipril
- Made by
- BB FARMA (ITALIE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Ramipril). It describes the substance, not this exact product.
Ramipril and ramiprilat inhibit ACE in human subjects and animals.
Angiotensin converting enzyme is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II.
Ramipril is almost completely metabolized to ramiprilat, which has about 6 times the ACE inhibitory activity of ramipril, and to the diketopiperazine ester, the diketopiperazine acid, and the glucuronides of ramipril and ramiprilat, all of which are inactive.
After oral administration of ramipril, about 60% of the parent drug and its metabolites are eliminated in the urine, and about 40% is found in the feces.
The extent of absorption is at least 50% to 60%, and is not significantly influenced by the presence of food in the gastrointestinal tract, although the rate of absorption is reduced.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-04
Safety of the active substance
From the US prescribing label for the same active substance (Ramipril). It describes the substance, not this exact product.
WARNING: FETAL TOXICITY When pregnancy is detected, discontinue ramipril as soon as possible [see Warnings and Precautions (5.6) ].
- Ramipril capsules are contraindicated in patients who are hypersensitive to this product or any other ACE inhibitor (e.g., a patient who has experienced angioedema during therapy with any other ACE inhibitor).
- Do not administer ramipril capsules within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor [see Warnings and Precautions (5.1) ].
- Do not co-administer ramipril capsules with aliskiren:. in patients with diabetes Angioedema related to previous treatment with an ACE inhibitor, or a history of hereditary or idiopathic angioedema (4).
- Do not co-administer aliskiren with ramipril capsules in patients with diabetes (4).
The most frequent clinical side effects (possibly or probably related to study drug) reported by patients receiving ramipril in placebo-controlled trials were: headache (5.4%), dizziness (2.2%), and fatigue or asthenia (2%), but only the last one was more common in ramipril patients than in patients given placebo.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
Spain13 matching products
Details
| Made by | BB FARMA (ITALIE) |
|---|---|
| Active substance | Ramipril |
| Strength | 2,5 mg |
| Form | comprimé sécable |
| Route | orale |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Autorisation d'importation parallèle |
| Name in the register | TRIATEC 2,5 mg, comprimé sécable |
| Packs | plaquette(s) thermoformée(s) PVC-Aluminium de 30 comprimé(s) |
| CIS | 64987864 |
| CIP13 | 3400949001361 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
9 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- comprimé sécable8 products
2,5 mg3
2,5 mg · 3 companies
- BB FARMA (ITALIE) · this page
- DIFARMED (ESPAGNE)
- SANOFI WINTHROP INDUSTRIE
5 mg3
5 mg · 3 companies
10 mg2
10 mg · 2 companies
- comprimé1 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.